SEC Info - Lipocine Inc. - ‘S-1MEF’ on 11/26/13

SEC Info℠

Home

Help

Please Sign In

Lipocine Inc. – ‘S-1MEF’ on 11/26/13 – EX-23.1

On: Tuesday, 11/26/13, at 8:04pm ET · Effective: 11/26/13 · Accession #: 1193125-13-455439 · File #s: 333-192069, 333-192575

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/26/13  Lipocine Inc.                     S-1MEF     11/26/13    4:51K                                    RR Donnelley/FA

Registration of Additional Securities — Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1MEF      Registration of Additional Securities               HTML     32K 
 2: EX-5.1      Opinion re: Legality                                HTML     10K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML      6K 
 4: EX-23.2     Consent of Experts or Counsel                       HTML      8K

EX-23.1 — Consent of Experts or Counsel

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Lipocine Inc.:

We consent to the use of our report dated July 24, 2013, except as to Note 2, which is as of November 12, 2013, with respect to the balance sheets of Lipocine Inc. as of December 31, 2012 and 2011, and the related statements of operations, changes in stockholders’ equity, and cash flows for each of the years in the two-year period ended December 31, 2012, incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

Salt Lake City, Utah

November 26, 2013

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-1MEF’ Filing	Date	Other Filings

Filed on / Effective on:	11/26/13
	11/12/13
	7/24/13	3, 8-K, 8-K/A
	12/31/12	10-K
	12/31/11	10-K, 10-K/A
		List all Filings

↑Top